Health & Medical
Medicare, Medicaid, HIPAA, ACA, prescription drugs, and FDA regulation.
Featured Overview
A Federal overview for Health & Medical is not available yet. This hub still shows related articles, common questions, and recent enacted changes while coverage is generated.
Browse the hub content below while the primary overview is still being generated.
Recent Law Changes
Amendment of Class E5 Airspace Over Elizabeth City, NC
This amendment changes the airspace regulations over Elizabeth City, North Carolina. Previously, there was no specific mention of Class E airspace extending upward from 700 feet above the surface within a 6-mile radius around Sentara Albemarle Medical Center Heliport. Now, this area is designated as part of Class E5 airspace due to new instrument approach procedures for the heliport. This change affects pilots and air traffic controllers operating in or near this airspace. The amendment takes effect on July 9, 2026.
Updated Insurance Requirements for Multi-Family Housing Programs
This law updates insurance requirements under the USDA's Rural Development Multi-Family Housing Direct Loan and Grant programs. Before this change, insurance coverage types, amounts, and deductibles were not aligned with industry standards. Now, these will be adjusted to match affordable housing norms, simplifying coverage and deductible limits for better customer experience. The changes affect those involved in MFH programs, including property owners and tenants. This new rule takes effect on May 20, 2026.
Placement of CUMYL-PEGACLONE in Schedule I
This law places a substance known as CUMYL-PEGACLONE into Schedule I of the Controlled Substances Act. This means it is now considered to have a high potential for abuse and no accepted medical use, similar to substances like heroin or LSD. The change affects manufacturers, distributors, researchers, and anyone who possesses this substance. It imposes strict regulatory controls and sanctions on handling CUMYL-PEGACLONE. This action takes effect immediately.
New Classification for Devices Detecting Microorganism Nucleic Acids and Resistance Markers
The FDA has classified a new device that detects and identifies microorganism nucleic acids and resistance markers from patients with suspected orthopedic infections into Class II, which includes special controls. This classification ensures the safety and effectiveness of these devices while reducing regulatory burdens to enhance patient access to innovative medical technology. The change affects manufacturers of such devices who must now adhere to the new class II requirements.
Classification Change for External Condoms
This law classifies external condoms used for anal or vaginal intercourse into Class II by the FDA. This classification means these devices will now have special controls to ensure their safety and effectiveness. The change aims to enhance patient access to beneficial innovative devices while reducing regulatory burdens on manufacturers. It takes effect immediately.
Classification of Circulating Tumor Cell Enrichment Device
This new regulation classifies a medical device called the circulating tumor cell enrichment device into Class II under FDA regulations. Previously, there was no specific classification for this type of device. The special controls identified in this order will ensure its safety and effectiveness. This change affects manufacturers who produce these devices as well as patients who may benefit from improved access to innovative diagnostic tools. It takes effect immediately.
Articles & Guides
JURISDICTION
Requested Federal.
Hub content is currently scoped to Federal.